Neuroendocrine cancer network
Biography I was born in a small picturesque town in Northeast Romania, a region known for its deeply embedded traditions and friendly inhabitants.
Being raised by science-loving parents, it was only natural that I would also develop a passion and profound respect for all rigorous academic disciplines.
I thus graduated from high neuroendocrine cancer network with a major in mathematics and physics. My strong background in exact sciences, together with my long love for biology, led me to to pursue a career in medicine.
Groningen Pituitary and Skull Base Symposium Cancerul pancreatic Sevastita Iordache - Google Scholar Citations Neuroendocrine cancer network Sesiunile științifice, împreună cu Masterclass-ul de Chirurgie Robotică, două cursuri pre-Congres și al doilea webinar live IFSO-EC au oferit participanților informații prețioase cu impact neuroendocrine cancer network tehnicilor de chirurgie minim invazivă. In addition, since she works as neuroendocrine cancer network Faculty Staff of the Master in Science Neuroendocrine cancer network Methods and Technology in Diagnosis organized by the Department of Biomedical Scineces, University of West Attica [lectures on hereditary and familial endocrine cancer]. Sinceshe is Director of her own private medical practice where she works as a consultant surgeon with special interest in Endocrine Surgery and Breast Surgery.
During medical school, in between clinical rotations, I volunteered in a research lab within the Pharmacology Department where I studied the effects of Rifampicin and ethanol on the immune system in a mouse model of tuberculosis.
This peek into scientific research radically changed my focus away from medicine and toward a life in a lab. I pursued my newly found passion for research by applying for PhD programs in the US.
Under Dr. During my time at Fox Chase, I took on several projects aiming to understand the role of p21 activated kinases Pak in cancer.
Meniu de navigare Când e indicată testarea CA Pancreatită redusă potență A high- protein diet with added fat puts more strain on the pancreas by forcing it to work harder.
My future plans are to continue to investigate the molecular pathways and biological events associated with development and progression of cancer in an academic or industry setting. At the same time, I feel strongly about the need to spread the word about the amazing world of science and discoveries and I plan to do my share in communicating various science advances by participating in career talks, seminars or scientific forums.
Research Overview pactivated kinases Paks have been shown to regulate cytoskeleton rearrangements, cell proliferation, attachment, and migration in a variety of cellular contexts, including endothelial cells. However, the role of endothelial Pak in embryo development has not been reported, and currently, there is no consensus on the endothelial function of individual Pak isoforms in adult tissues, in particular pactivated kinase 2 Pak2the main Pak isoform expressed in endothelial cells.
To address these unknowns, we employed genetic and molecular studies that showed that Pak2, but not Pak1, is a critical mediator of development and maintenance of endothelial cell function in adult tissues.
We found that during development Pak2 has a critical role in the endothelium since deletion of Pak2 results in early embryo lethality.
In the adult, we neuroendocrine cancer network that knockout of Pak2 in the vasculature results in endothelial cell apoptosis and increased vascular permeability, which closely resembles the phenotype induced by the loss of Erk5. Mol Cell Biol.
Aggressive variants of prostate cancer - Are we ready to neuroendocrine cancer network specific treatment right now? Cancer Treat Rev. In most cases, prostate cancer essentially depends on androgen receptor signaling axis, even in castration-resistant setting, and hence may be targeted by second generation hormonal therapy. However, a subset of patients bears androgen-independent cancer biology with a short-term response to hormonal treatment, early and extensive visceral metastases, low PSA levels and poor outcomes. Identification and specific management of these rapidly fatal malignancies is of an unmet medical need since their classification and utilized therapeutic regimens vary significantly.